Skip to main content

Advertisement

Log in

Association of rheumatoid arthritis with mortality in chronic kidney disease: a cohort study

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Background

Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular disease (CVD) as well as with an increased risk of chronic kidney disease (CKD), also a known cardiovascular risk factor. However, it is not known if RA is a predictor of adverse outcomes in patients with CKD. We hypothesized that among a cohort of patients with CKD, RA would be associated with an increased risk of mortality.

Materials and methods

We conducted a retrospective study of 3939 participants with CKD from the prospective Chronic Renal Insufficiency Cohort (CRIC) study. The primary outcome of interest was all-cause mortality. Secondary outcomes included CKD progression (defined as end-stage kidney disease or 50% decline in estimated glomerular filtration rate), cardiovascular endpoints, and composite of myocardial infarction, cerebrovascular accident, heart failure, or death. Multivariable Cox proportional hazards regression was utilized, adjusting for potential confounders including age, sex, race/ethnicity, body mass index, current smoker, and education.

Results

The study cohort included 83 participants with RA on a disease modifying anti-rheumatic drug (DMARD). In the adjusted analysis, CKD-RA status was significantly associated with an increased risk of death (adjusted HR, aHR, 1.73 (1.27, 2.35)) and composite outcome (aHR 1.65 (1.27–2.15)) even after adjusting for traditional risk factors. Similar statistically significant associations were observed between CKD-RA and other secondary outcomes except for CKD progression.

Conclusion

RA was associated with higher mortality among individuals with CKD but not progressive renal decline. Further studies evaluating the mechanisms behind this association are needed.

Key Points

Rheumatoid arthritis (RA) is associated with an increased risk of cardiovascular disease (CVD) as well as with an increased risk of chronic kidney disease (CKD), also a known cardiovascular risk factor. However, it is not known if RA is an independent predictor of adverse outcomes in patients with CKD

In this study, we observed that CKD patients with RA experience higher mortality as well as an increased risk of CVD compared to patients with CKD without comorbid RA

These data provide rationale for more aggressive monitoring for CVD in patients with CKD and RA. They also underscore the need for determining which interventions can help decrease the burden of mortality in these patients

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D (2012) Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 71(9):1524–1529

    Article  Google Scholar 

  2. Blum A, Adawi M (2019) Rheumatoid arthritis (RA) and cardiovascular disease. Autoimmun Rev 18(7):679–690

    Article  CAS  Google Scholar 

  3. Kochi M, Kohagura K, Shiohira Y, Iseki K, Ohya Y (2018) Chronic kidney disease, inflammation, and cardiovascular disease risk in rheumatoid arthritis. J Cardiol 71(3):277–283

    Article  Google Scholar 

  4. Fragoulis GE, Panayotidis I, Nikiphorou E (2020) Cardiovascular risk in rheumatoid arthritis and mechanistic links: from pathophysiology to treatment. Curr Vasc Pharmacol 18(5):431–446

    Article  CAS  Google Scholar 

  5. Davis JM III, Roger VL, Crowson CS, Kremers HM, Therneau TM, Gabriel SE (2008) The presentation and outcome of heart failure in patients with rheumatoid arthritis differs from that in the general population. Arthritis Rheum 58(9):2603–2611

    Article  Google Scholar 

  6. Giles JT, Simon LS, Pope J, Paik JS, Grabner M, Quebe A, Kannowski CL, Salinas CA, Curtis JR (2021) Prevalence of renal impairment in a US commercially insured rheumatoid arthritis population: a retrospective analysis. Rheumatol Ther 8(3):1383–1391

    Article  Google Scholar 

  7. Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED, Go AS, Hamm LL et al (2003) The chronic renal insufficiency cohort (CRIC) study: design and methods. J Am Soc Nephrol 14(7 Suppl 2):S148-153

    Article  Google Scholar 

  8. Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J et al (2009) Chronic renal insufficiency cohort (CRIC) study: baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol 4(8):1302–1311

    Article  Google Scholar 

  9. Formica MK, McAlindon TE, Lash TL, Demissie S, Rosenberg L (2010) Validity of self-reported rheumatoid arthritis in a large cohort: results from the Black Women’s Health Study. Arthritis Care Res 62(2):235–241

    Google Scholar 

  10. Bansal N, McCulloch CE, Lin F, Alper A, Anderson AH, Cuevas M, Go AS, Kallem R, Kusek JW, Lora CM et al (2017) Blood pressure and risk of cardiovascular events in patients on chronic hemodialysis: the CRIC study (chronic renal insufficiency cohort). Hypertension 70(2):435–443

    Article  CAS  Google Scholar 

  11. Mills KT, Chen J, Yang W, Appel LJ, Kusek JW, Alper A, Delafontaine P, Keane MG, Mohler E, Ojo A et al (2016) Sodium excretion and the risk of cardiovascular disease in patients with chronic kidney disease. JAMA 315(20):2200–2210

    Article  CAS  Google Scholar 

  12. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, Stampfer MJ, Curhan GC (2003) Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 107(9):1303–1307

    Article  Google Scholar 

  13. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59(12):1690–1697

    Article  Google Scholar 

  14. Sokka T, Abelson B, Pincus T (2008) Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol 26(5 Suppl 51):S35-61

    CAS  PubMed  Google Scholar 

  15. Zhang C (2008) The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol 103(5):398–406

    Article  CAS  Google Scholar 

  16. Alemao E, Bao Y, Weinblatt ME, Shadick N (2020) Association of seropositivity and mortality in rheumatoid arthritis and the impact of treatment with disease-modifying antirheumatic drugs: results from a real-world study. Arthritis Care Res (Hoboken) 72(2):176–183

    Article  CAS  Google Scholar 

  17. Goodson NJ, Symmons DP, Scott DG, Bunn D, Lunt M, Silman AJ (2005) Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort. Arthritis Rheum 52(8):2293–2299

    Article  CAS  Google Scholar 

  18. Blake GJ, Ridker PM (2001) Novel clinical markers of vascular wall inflammation. Circ Res 89(9):763–771

    Article  CAS  Google Scholar 

  19. Pasceri V, Willerson JT, Yeh ET (2000) Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 102(18):2165–2168

    Article  CAS  Google Scholar 

  20. Zwaka TP, Hombach V, Torzewski J (2001) C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 103(9):1194–1197

    Article  CAS  Google Scholar 

  21. Keller C, Katz R, Sarnak MJ, Fried LF, Kestenbaum B, Cushman M, Shlipak MG (2010) Inflammatory biomarkers and decline in kidney function in the elderly: the Cardiovascular Health Study. Nephrol Dial Transplant 25(1):119–124

    Article  CAS  Google Scholar 

  22. Ortega O, Rodriguez I, Gallar P, Carreño A, Ortiz M, Espejo B, Jimenez J, Gutierrez M, Oliet A, Vigil A (2002) Significance of high C-reactive protein levels in pre-dialysis patients. Nephrol Dial Transplant 17(6):1105–1109

    Article  Google Scholar 

  23. Sarnak MJ, Poindexter A, Wang SR, Beck GJ, Kusek JW, Marcovina SM, Greene T, Levey AS (2002) Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int 62(6):2208–2215

    Article  CAS  Google Scholar 

  24. Tonelli M, Sacks F, Pfeffer M, Jhangri GS, Curhan G (2005) Biomarkers of inflammation and progression of chronic kidney disease. Kidney Int 68(1):237–245

    Article  CAS  Google Scholar 

  25. Cheng YJ, Cheng XY, Zhang YM, Wang F, Wang X, Meng LQ, Liu G, Cui Z, Zhao MH (2022) Effects ofhydroxychloroquine on proteinuria in membranous nephropathy. J Nephrol 35(4):1145–1157

    Article  CAS  Google Scholar 

  26. Rodrigues JC, Bargman JM (2018) Antimalarial drugs for the prevention of chronic kidney disease in patients with rheumatoid arthritis: the importance of controlling chronic inflammation? Clin J Am Soc Nephrol 13(5):679–680

    Article  Google Scholar 

  27. Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, Siu S, Kraft J, Lynde C, Pope J et al (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis 74(3):480–489

    Article  CAS  Google Scholar 

  28. Panoulas VF, Douglas KM, Stavropoulos-Kalinoglou A, Metsios GS, Nightingale P, Kita MD, Elisaf MS, Kitas GD (2008) Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis. Rheumatology (Oxford) 47(1):72–75

    Article  CAS  Google Scholar 

  29. del Rincón I, Battafarano DF, Restrepo JF, Erikson JM, Escalante A (2014) Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatol 66(2):264–272

    Article  Google Scholar 

  30. Davis JM 3rd, Maradit Kremers H, Crowson CS, Nicola PJ, Ballman KV, Therneau TM, Roger VL, Gabriel SE (2007) Glucocorticoids and cardiovascular events in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 56(3):820–830

    Article  CAS  Google Scholar 

  31. Movahedi M, Costello R, Lunt M, Pye SR, Sergeant JC, Dixon WG (2016) Oral glucocorticoid therapy and all-cause and cause-specific mortality in patients with rheumatoid arthritis: a retrospective cohort study. Eur J Epidemiol 31(10):1045–1055

    Article  CAS  Google Scholar 

  32. Mantel Ä, Holmqvist M, Andersson DC, Lund LH, Askling J (2017) Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure. J Am Coll Cardiol 69(10):1275–1285

    Article  Google Scholar 

  33. Aslam F, Bandeali SJ, Khan NA, Alam M (2013) Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res (Hoboken) 65(4):534–543

    Article  Google Scholar 

  34. Fan F, Galvin A, Fang L, White DA, Moore XL, Sparrow M, Cicuttini F, Dart AM (2014) Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease. J Inflamm (Lond) 11(1):29

    Article  Google Scholar 

  35. Paulus WJ, Tschöpe C (2013) A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62(4):263–271

    Article  Google Scholar 

  36. Myasoedova E, Crowson CS, Nicola PJ, Maradit-Kremers H, Davis JM 3rd, Roger VL, Therneau TM, Gabriel SE (2011) The influence of rheumatoid arthritis disease characteristics on heart failure. J Rheumatol 38(8):1601–1606

    Article  Google Scholar 

  37. Chiu HY, Huang HL, Li CH, Chen HA, Yeh CL, Chiu SH, Lin WC, Cheng YP, Tsai TF, Ho SY (2015) Increased risk of chronic kidney disease in rheumatoid arthritis associated with cardiovascular complications - a national population-based cohort study. PLoS ONE 10(9):e0136508

    Article  Google Scholar 

  38. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52(3):722–732

    Article  Google Scholar 

Download references

Acknowledgements

The Chronic Renal Insufficiency Cohort Study (CRIC) was conducted by the CRIC Study Investigators and supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The data from the CRIC reported here were supplied by the NIDDK Central Repositories. This manuscript was not prepared in collaboration with Investigators of the CRIC study and does not necessarily reflect the opinions or views of the CRIC study, the NIDDK Central Repositories, or the NIDDK.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Namrata Singh.

Ethics declarations

Disclosures

None.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This study was presented as a poster at the EULAR 2021 virtual Congress. Citation: Ann Rheum Dis, volume 80, supplement 1, year 2021, page 476.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ezeanuna, M., Prince, D., Alexander, S. et al. Association of rheumatoid arthritis with mortality in chronic kidney disease: a cohort study. Clin Rheumatol 41, 2669–2676 (2022). https://doi.org/10.1007/s10067-022-06223-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-022-06223-x

Keywords

Navigation